You are here

cancer

A ‘widening gap’ in access to new cancer meds drives efforts from City of Hope and Bristol Myers

Pharma Voice

Thu, 06/6/24 - 11:36 am

Bristol Myers Squibb

Clinical-stage cancer biotech Actuate latest to eye summer IPO

Fierce Biotech

Tue, 05/28/24 - 10:53 am

Actuate Therapeutics

AstraZeneca pays $19M to Harbour BioMed's Nona for preclinical cancer antibodies

Fierce Biotech

Thu, 05/23/24 - 10:47 am

Nona Biosciences

FogPharma, Artbio join forces to design a different radiopharma drug

BioPharma Dive

Tue, 05/14/24 - 11:00 pm

radiopharmaceuticals

Could Cancer Vaccines Be the Next Big Breakthrough in Immunotherapy?

BioSpace

Mon, 05/13/24 - 10:50 am

cancer vaccines

How mRNA vaccines could be personalized cancer cures

Axios

Tue, 05/7/24 - 10:59 am

personalized medicine

Delphia starts up with $67M to make a new type of cancer drug

BioPharma Dive

Thu, 05/2/24 - 11:28 am

Delphia Therapeutics

activation lethality

Emergence of ADCs as the “hot, new technology”

Pharmaphorum

Thu, 04/25/24 - 11:39 am

antibody-drug conjugate

Oncologists' meetings with drug reps don't help cancer patients live longer

NPR

Tue, 04/23/24 - 10:49 am

pharma marketing

FDA mandates label updates on CAR-T cancer therapies

Reuters

Thu, 04/18/24 - 10:34 pm

Gilead Sciences

Bristol Myers Squibb

Roche, Adaptimmune part ways on cell therapy research

BioPharma Dive

Sun, 04/14/24 - 01:26 pm

Vaccines, next-gen approaches target the toughest cancers: AACR

BioSpace

Fri, 04/12/24 - 11:36 am

Novartis begins tender offer for cancer-focused MorphoSys

Reuters

Thu, 04/11/24 - 11:54 am

Sino Biopharm and Boehringer Ingelheim enter into strategic collaboration

China Daily

Mon, 04/8/24 - 05:54 pm

Boehinger Ingelheim

Sanofi to settle 4,000 Zantac cancer lawsuits in US state courts

Reuters

Wed, 04/3/24 - 10:25 pm

Gilead bets on Xilio cancer drug as biotech restructures

BioPharma Dive

Thu, 03/28/24 - 11:54 am

Gilead Sciences

Xilio Therapeutics

Boundless Bio breaks IPO lull with $100M fundraise

BioPharma Dive

Wed, 03/27/24 - 10:37 pm

Arch Venture Partners

New research highlights potential of HIF Inhibition as a therapeutic approach for cancers

Biopharma Reporter

Tue, 03/26/24 - 10:59 am

Curve Therapeutics

Merck, Others Look to Immunotherapy Combos as Next Frontier in Oncology

BioSpace

Mon, 03/25/24 - 11:32 am

Thermo Fisher, Bayer partner to develop companion diagnostics

BioPharma Dive

Thu, 03/21/24 - 11:33 am

Thermo Fisher Scientific

companion diagnostics

Pages